Hemostatic Complications in Hematopoietic Stem Cell Transplantation
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Hemostatic disorders are common and potentially fatal complications in patients undergoing
hematopoietic stem-cell transplantation (HSCT). Limited data exist on early diagnosis and
prevention of these complications. The investigators undertook this prospective study to
determine the incidence, predictor factors, specific pathogenesis, management and survival
specially for patients with thrombotic and bleeding complication to better improve outcomes.
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University